Record NNP B-NP O
date NN I-NP O
: : O O
2092-02-13 CD O B-DATE
Problems NNS B-NP O
Health NNP B-NP O
maintenance NN I-NP O
Depression NN B-NP O
Osteoporosis NN B-NP O
GERD NNP B-NP O
HTN . O O
Interstitial NNP B-NP O
nephritis NN I-NP O
H/O NNP B-NP O
Systemic NNP I-NP O
lupus FW I-NP O
erythematosis NN I-NP O
: : O O
Diagnosed VBN B-VP O
2083 CD B-NP B-DATE
with IN B-PP O
ANA NNP B-NP O
+ NNP I-NP O
, , O O
1:5120 CD B-NP O
speckled JJ I-NP O
pattern NN I-NP O
; : O O
Anti NNP B-NP O
Ro+ NNP I-NP O
. . O O
Abdominal JJ B-NP O
pain NN I-NP O
H/O NNP B-NP O
Coronary NNP I-NP O
artery NN I-NP O
disease NN I-NP O
: : O O
S/p NNP B-NP O
RCA NNP I-NP O
PTCA NNP I-NP O
12/2082 CD I-NP B-DATE
. . O O
Narrative JJ B-NP O
History NN I-NP O
Pt JJ B-NP O
reutrns NNS I-NP O
for IN B-PP O
f/u NN B-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
taking VBG I-VP O
lipitor NN B-NP O
for IN B-PP O
several JJ B-NP O
weeks NNS I-NP O
as IN B-ADVP O
ran VBD B-VP O
out RB B-ADVP O
and CC O O
did VBD B-VP O
not RB I-VP O
refull VB I-VP O
Rx NNP B-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
had VBN I-VP O
R NN B-NP O
shoulder NN I-NP O
pain NN I-NP O
for IN B-PP O
about IN B-NP O
one CD I-NP O
month NN I-NP O
. . O O
Pain NNP B-NP O
is VBZ B-VP O
an DT B-NP O
aching VBG I-NP O
quality NN I-NP O
, , O O
minimally RB B-VP O
alleviated VBN I-VP O
by IN B-PP O
tylenol NN B-NP O
, , O O
exacerbated VBN B-VP O
by IN B-PP O
moving VBG B-NP O
rotating VBG I-NP O
shoulder NN I-NP O
. . O O
Does VBZ B-VP O
not RB I-VP O
have VB I-VP O
frozen VBN I-VP O
shoulder NN B-NP O
or CC I-NP O
sensation NN I-NP O
of IN B-PP O
morning NN B-NP O
stiffness NN I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
able JJ B-ADJP O
to TO B-VP O
continue VB I-VP O
all DT B-NP O
IADL NNP I-NP O
activities NNS I-NP O
requiring VBG B-VP O
use NN B-NP O
of IN B-PP O
the DT B-NP O
joint JJ I-NP O
but CC O O
notes VBZ B-VP O
the DT B-NP O
pain NN I-NP O
has VBZ B-VP O
become VBN I-VP O
increasingly RB B-NP O
bothersome DT I-NP O
. . O O
She PRP B-NP O
notes VBZ B-VP O
no DT B-NP O
weakness NN I-NP O
of IN B-PP O
her PRP$ B-NP O
R NN I-NP O
arm NN I-NP O
, , O O
no DT B-NP O
dysesthesias NNS I-NP O
or CC I-NP O
paresthesias NNS I-NP O
, , O O
swelling VBG B-VP O
, , O O
or CC O O
history NN B-NP O
of IN B-PP O
injury NN B-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
noted VBN I-VP O
burning VBG I-VP O
pain NN B-NP O
in IN B-PP O
lower JJR B-NP O
extremities NNS I-NP O
, , O O
stocking VBG B-VP O
distribution NN B-NP O
x NN I-NP O
1 CD B-NP O
year NN I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
pain NN B-NP O
described VBN B-VP O
as IN B-PP O
"pins NNS B-NP O
" '' O O
from IN B-PP O
bottom JJ B-NP O
of IN B-PP O
foot NN B-NP O
extending VBG B-VP O
up IN B-SBAR O
both DT B-NP O
legs NNS I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
a DT B-NP O
burning VBG I-NP O
sensation NN I-NP O
of IN B-PP O
both DT B-NP O
legs NNS I-NP O
that IN B-PP O
she PRP B-NP O
notices NNS B-VP O
particularly RB B-ADVP O
at IN B-PP O
night NN B-NP O
. . O O
Walking VB O O
does VBZ B-VP O
not RB I-VP O
exacerbate VB I-VP O
or CC I-VP O
alleviate VB I-VP O
this DT B-NP O
sensation NN I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
not RB I-VP O
used VBN I-VP O
anything NN B-NP O
to TO B-VP O
relieve VB I-VP O
the DT B-NP O
discomfort NN I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
no DT B-NP O
symptoms NNS I-NP O
of IN B-PP O
claudication NN B-NP O
, , O O
no DT B-NP O
reported VBD I-NP O
cyanosis NN I-NP O
of IN B-PP O
her PRP$ B-NP O
LE JJ I-NP O
digits NNS I-NP O
, , O O
and CC O O
no DT B-NP O
LE JJ I-NP O
edema NN I-NP O
. . O O
Allergies . O O
* VB B-NP O
Celebrex NNP I-NP O
- : O O
SOB NN B-VP O
: : O O
" `` O O
that IN B-NP O
triggered VBD B-VP O
her PRP$ B-NP O
asthma NN I-NP O
" '' O O
Medications NNS B-NP O
Aspirin NNP B-NP O
(ACETYLSALICYLIC NN I-NP O
Acid NN I-NP O
) -RRB- I-NP O
81 CD I-NP O
MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Calcium NNP B-NP O
Gluconate NNP I-NP O
500MG NNP I-NP O
, , O O
2 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
x1 . O O
Vitamin NN B-NP O
D NNP I-NP O
( -LRB- I-NP O
ERGOCALCIFEROL NNP I-NP O
) -RRB- I-NP O
PO NNP I-NP O
QD . O O
Nitroglycerin NNP B-NP O
1/150 CD I-NP O
( -LRB- I-NP O
0.4 CD I-NP O
Mg NN I-NP O
) -RRB- O O
1 CD B-NP O
TAB NNP I-NP O
SL NNP I-NP O
: : O O
PRN NN B-NP O
Nifedipine NNP B-NP O
( -LRB- I-NP O
EXTENDED NNP I-NP O
Release NNP I-NP O
) -RRB- I-NP O
90MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
HYDROXYCHLOROQUINE NNP B-NP O
200MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
BID NNP I-NP O
x NNP I-NP O
30 CD I-NP O
day( NN I-NP O
s VBZ B-VP O
) -RRB- O O
ATENOLOL NNP B-NP O
50MG JJ I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Protonix NNP B-NP O
( -LRB- I-NP O
PANTOPRAZOLE NN I-NP O
) -RRB- I-NP O
40MG CD I-NP O
, , I-NP O
1 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD NNP I-NP O
x NNP I-NP O
30 CD I-NP O
day( NN I-NP O
s VBZ B-VP O
) -RRB- O O
PREDNISONE JJ B-NP O
10MG JJ I-NP O
, , I-NP O
1 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NNP I-NP O
QD NNP I-NP O
x NN I-NP O
30 CD B-NP O
day( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Isosorbide NNP B-NP O
Dinitrate NNP I-NP O
30MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Vioxx NNP B-NP O
( -LRB- I-NP O
ROFECOXIB NNP I-NP O
) -RRB- I-NP O
25MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD NNP I-NP O
x NNP I-NP O
90 CD I-NP O
day( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Amitriptyline NNP B-NP O
Hcl NNP I-NP O
25MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NNP I-NP O
QHS NNP I-NP O
x NN I-NP O
90 CD B-NP O
day( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Lipitor NNP B-NP O
( -LRB- I-NP O
ATORVASTATIN NNP I-NP O
) -RRB- I-NP O
20MG NNP I-NP O
, , O O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD NNP I-NP O
x NNP I-NP O
90 CD I-NP O
day( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Review NNP B-NP O
of IN I-NP O
Systems NNPS O O
Thirteen CD B-NP O
point NN I-NP O
ROS NNP B-NP O
is VBZ B-VP O
negative JJ B-ADJP O
in IN B-PP O
detail NN B-NP O
except IN B-PP O
as IN I-PP O
noted VBN B-NP O
in IN B-PP O
the DT B-NP O
HPI. NNP I-NP O
Vital JJ B-NP O
Signs NNS I-NP O
BLOOD NN B-NP O
PRESSURE JJ I-NP O
120/64 CD I-NP O
Left VBN I-NP O
Arm NN I-NP O
PULSE NNP B-NP O
68 CD I-NP O
Regular . O O
RESPIRATORY NN B-NP O
RATE NN I-NP O
14 CD I-NP O
Regular NNP I-NP O
WEIGHT NNP B-NP O
202 CD I-NP O
lb NN I-NP O
Physical NNP B-NP O
Exam NNP I-NP O
Looks VBZ B-VP O
stated VBN B-NP O
age NN I-NP O
, , I-NP O
cushingoid NN I-NP O
habitus NN I-NP O
w/ VBN I-NP O
moon NN I-NP O
facies NNS I-NP O
, , O O
well RB B-VP O
groomed VBN I-VP O
, , O O
NAD. . O O
HEENT NNP B-NP O
- : O O
PERRL NN B-NP O
, , O O
EOMI NNP B-NP O
. . I-NP O
Sclerae NNP I-NP O
anicteric JJ I-NP O
, , I-NP O
conjunctivae JJ I-NP O
pale JJ I-NP O
. . O O
No DT O O
sinus NNPS B-NP O
tenderness NN B-VP O
. . B-NP O
Oropharynx NNP I-NP O
moist JJ I-NP O
, , O O
dentition IN B-PP O
good JJ B-NP O
, , O O
no DT B-NP O
oral JJ I-NP O
lesions NNS I-NP O
. . O O
Neck NN B-NP O
supple NN I-NP O
, , O O
no DT B-NP O
LAN NNP I-NP O
, , O O
no DT B-NP O
masses NNS I-NP O
. . O O
Chest NNP B-NP O
- : O O
CTA NNP B-NP O
B. NNP I-NP O
CV NNP B-NP O
- : O O
RRR NN B-NP O
. . B-NP O
Nl NNP I-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
; : O O
distant JJ B-NP O
heart NN I-NP O
sounds VBZ B-VP O
. . O O
No DT B-NP O
MRG. NNP I-NP O
JVP NNP I-NP O
flat JJ I-NP O
. . O O
DP NNP O O
2+ VBD B-VP O
B. NNP B-NP O
Abd NNP B-NP O
- : O O
NABS NNP B-NP O
, , O O
TTP NNP B-NP O
LUQ NNP I-NP O
w/ VBD B-VP O
mild JJ B-NP O
rebound NN I-NP O
, , O O
no DT B-NP O
guarding VBG I-NP O
. . O O
Ext JJ O O
- : O O
No DT B-NP O
edema NN I-NP O
, , O O
cyanosis NN B-NP O
, , O O
clubbing VBG B-VP O
. . B-NP O
FROM NNP I-NP O
B. NNP I-NP O
No DT B-NP O
evidence NN I-NP O
of IN B-PP O
capsulitis NN B-NP O
of IN B-PP O
R NN B-NP O
shoulder NN I-NP O
. . O O
Has VBZ B-VP O
pain NN B-NP O
with IN B-PP O
cross NN B-NP O
over IN B-PP O
manouver NN B-NP O
and CC I-NP O
impingement NN I-NP O
sign NN I-NP O
. . O O
Tender NN B-ADJP O
to TO B-PP O
palpation NN B-NP O
along IN B-PP O
anterior JJ B-NP O
aspect NN I-NP O
of IN B-PP O
acromioclavicular JJ B-NP O
joint NN I-NP O
. . O O
Pulses NNS B-NP O
in IN B-PP O
LE NN B-NP O
are VBP B-VP O
R NN B-NP O
DP NNP I-NP O
1+ CD I-NP O
PT NNP I-NP O
2+ CD I-NP O
; : O O
L NNP B-NP O
DP NNP I-NP O
2+ VBD B-VP O
PT NNP B-NP O
2+ CD I-NP O
. . O O
Health NNP B-NP O
Maintenance NNP I-NP O
Influenza NNP B-NP O
Vaccine NNP I-NP O
10/23/2091 CD I-NP B-DATE
Lot NNP B-NP O
# # I-NP O
771830 CD O B-IDNUM
Right RB B-ADVP O
Arm NN O O
Breast NN B-NP O
Exam NNP I-NP O
03/27/2090 CD I-NP B-DATE
Bil NNP I-NP O
fibrocystic JJ I-NP O
appearance NN I-NP O
without IN B-PP O
dominant JJ B-NP O
mass NN I-NP O
or CC I-NP O
nipple NN I-NP O
discharge NN I-NP O
. . O O
No DT B-NP O
axillary NN I-NP O
lymphadenopathy NN I-NP O
or CC I-NP O
assymetry NN I-NP O
. . O O
No DT B-NP O
skin NN I-NP O
changes NNS I-NP O
. . O O
Cholesterol NNP B-NP O
03/27/2090 CD I-NP B-DATE
156 CD I-NP O
DESIRABLE NNP I-NP O
: : O O
<200 CD O O
Pap NNP B-NP O
Smear NNP I-NP O
08/14/2091 VBD B-VP B-DATE
See VB I-VP O
report NN B-NP O
in IN B-PP O
Results NNS B-NP O
UA-Protein NNP B-NP O
11/30/2091 CD I-NP B-DATE
1+ . O O
HBA1C NNP B-NP O
12/14/2091 CD I-NP B-DATE
6.90 CD O O
Triglycerides NNS B-NP O
03/27/2090 CD B-NP B-DATE
129 CD I-NP O
Cholesterol-LDL NNP B-NP O
01/07/2088 CD I-NP B-DATE
88 CD O O
Bone NN B-NP O
Density NNP B-NP O
05/18/2091 CD I-NP B-DATE
BMD-Hip . O O
Hct NNP B-NP O
( -LRB- I-NP O
Hematocrit NN I-NP O
) -RRB- I-NP O
12/13/2091 CD I-NP B-DATE
39.0 CD O O
Cholesterol-HDL NNP B-NP O
03/27/2090 CD I-NP B-DATE
42 CD O O
Assessment NNP B-NP O
and CC I-NP O
Plan NNP I-NP O
1 CD B-LST O
. . O O
Shoulder JJR B-NP O
pain NN I-NP O
. . O O
Impingement NNP B-NP O
sign NN I-NP O
, , O O
pain NN B-NP O
with IN B-PP O
cross NN B-NP O
over IN B-PP O
manouver NN B-NP O
, , O O
and CC O O
pain NN B-NP O
with IN B-PP O
use NN B-NP O
of IN B-PP O
shoulder NN B-NP O
to TO B-VP O
extend VB I-VP O
arm NN B-NP O
are VBP B-VP O
consistent JJ B-ADJP O
with IN B-PP O
rotator NN B-NP O
cuff NN I-NP O
injury NN I-NP O
. . O O
Check VB B-NP O
shoulder NN I-NP O
films NNS I-NP O
to TO B-VP O
exclude VB I-VP O
acromioclavicular JJ B-NP O
injury NN I-NP O
or CC O O
degenerative JJ B-NP O
process NN I-NP O
. . O O
Renew JJ B-NP O
Vioxx NNP I-NP O
prescription NN I-NP O
(avoiding NN I-NP O
NSAIDs NNS I-NP O
) -RRB- B-VP O
in IN B-PP O
this DT B-NP O
patient NN I-NP O
on IN B-PP O
prednisone NN B-NP O
, , O O
at IN B-PP O
risk NN B-NP O
for IN B-PP O
gastritis NN B-NP O
. . O O
2. . B-NP O
CAD. NNP I-NP O
Pt NNP B-NP O
had VBD B-VP O
negative JJ B-NP O
stress NN I-NP O
MIBI NNP I-NP O
in IN B-PP O
12/91 CD B-NP B-DATE
and CC O O
has VBZ B-VP O
not RB I-VP O
had VBN I-VP O
cardiology NN I-VP O
follow VB I-VP O
up RP B-PRT O
for IN B-NP O
multiple JJ I-NP O
years NNS I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
being VBG I-VP O
referred VBN I-VP O
to TO B-PP O
the DT B-NP O
Internal NNP I-NP O
Medicine NNP I-NP O
ward NN I-NP O
service NN I-NP O
for IN B-PP O
consultation NN B-NP O
. . O O
Specifically RB B-ADVP O
, , O O
she PRP B-NP O
remains VBZ B-VP O
on IN B-PP O
a DT B-NP O
nitrate NN I-NP O
( -LRB- I-NP O
isordil NN I-NP O
) -RRB- O O
which WDT B-NP O
may MD B-VP O
exacerbate VB I-VP O
GERD. NNP B-NP O
She PRP B-NP O
also RB B-ADVP O
merits NNS B-VP O
being VBG I-VP O
placed VBN I-VP O
on IN B-PP O
an DT B-NP O
ACE NNP I-NP O
inhibitor NN I-NP O
to TO B-VP O
prevent VB I-VP O
reinfarction NN B-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
well RB B-ADJP O
beta JJ I-ADJP O
blocked VBN B-VP O
and CC O O
her PRP$ B-NP O
BP NNP I-NP O
is VBZ B-VP O
well RB I-VP O
controlled VBN I-VP O
by IN B-PP O
the DT B-NP O
current JJ I-NP O
regimen NNS I-NP O
of IN B-PP O
atneolol NN B-NP O
and CC I-NP O
isordil NN I-NP O
. . O O
Checking NNP B-NP O
fasting VBG I-NP O
lipids NNS I-NP O
. . O O
3. . O O
SLE. . O O
She PRP B-NP O
is VBZ B-VP O
being VBG I-VP O
followed VBN I-VP O
by IN B-PP O
Dr. NNP B-NP O
Xie NNP I-NP B-DOCTOR
. . O O
She PRP B-NP O
and CC O O
I PRP B-NP O
are VBP B-VP O
curious JJ B-ADJP O
about IN B-PP O
her PRP$ B-NP O
prednisone NN I-NP O
dosing NN I-NP O
and CC O O
I PRP B-NP O
will MD B-VP O
discuss VB I-VP O
the DT B-NP O
regimen NNS I-NP O
with IN B-PP O
Dr. NNP B-NP O
Xie NNP I-NP B-DOCTOR
. . O O
4 LS O O
. . B-NP O
Prednisone NNP I-NP O
. . O O
Had VBD O O
BD NNP B-NP O
of IN B-PP O
hip NN B-NP O
last JJ B-NP O
year NN I-NP O
which WDT B-NP O
was VBD B-VP O
negative JJ B-ADJP O
; : O O
continues VBZ B-NP O
on IN B-PP O
calcium/vitamin NN B-NP O
D. NNP I-NP O
Needs NNS B-NP O
further JJ I-NP O
monitoring NN I-NP O
of IN B-PP O
HgbA1C JJ B-NP O
as IN B-SBAR O
elevated VBN B-VP O
from IN B-PP O
prior JJ B-NP O
measurements NNS I-NP O
and CC O O
hyperglycemic JJ B-ADJP O
from IN B-PP O
steroids NNS B-NP O
. . O O
5 CD B-NP O
. . O O
Mammogram NNP B-NP O
. . O O
Ordered VBN B-VP O
this DT B-NP O
visit NN I-NP O
for IN B-PP O
routine JJ B-NP O
HCM. . O O
6 CD B-NP O
. . O O
Pain NNP B-NP O
control NN I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
multiple JJ B-NP O
complaints NNS I-NP O
of IN B-PP O
chronic JJ B-NP O
pain NN I-NP O
which WDT B-NP O
are VBP B-VP O
not RB I-VP O
documented VBN I-VP O
in IN B-PP O
this DT B-NP O
note NN I-NP O
. . O O
She PRP B-NP O
has VBZ B-VP O
used VBN I-VP O
Vioxx NNP B-NP O
previously RB B-ADVP O
and CC O O
needs VBZ B-VP O
Stuart NNP B-NP B-HOSPITAL
Hospital NNP I-NP I-HOSPITAL
authorization NN I-NP O
which WDT B-NP O
is VBZ B-VP O
being VBG I-VP O
sought VBN I-VP O
following VBG I-VP O
this DT B-NP O
visit NN I-NP O
. . O O
7. . B-NP O
GERD. NNP I-NP O
Well-controlled JJ B-ADJP O
with IN B-PP O
new JJ B-NP O
regimen NNS I-NP O
of IN B-PP O
Protonix NNP B-NP O
40 CD I-NP O
BID. . O O
8. CD B-NP O
LE JJ I-NP O
dysesthesias NNS I-NP O
. . O O
Remeasuring VBG B-VP O
A1C NNP B-NP O
but CC O O
unlikely JJ B-ADJP O
to TO B-VP O
have VB I-VP O
microvascular JJ B-NP O
complications NNS I-NP O
without IN B-PP O
overt JJ B-ADJP O
DM. . O O
Starting VBG B-VP O
amitriptyline JJ B-NP O
. . I-NP O
Pt NNP I-NP O
educated VBN B-VP O
to TO I-VP O
take VB I-VP O
prior JJ B-ADJP O
to TO B-VP O
sleep VB I-VP O
and CC O O
will MD B-VP O
reassess VB I-VP O
if IN B-PP O
sx NN B-NP O
alleviated VBN B-VP O
. . O O
9 CD B-NP O
. . O O
F/u NNP B-NP O
. . O O
Pt NNP B-NP O
will MD B-VP O
follow VB I-VP O
up RP B-PRT O
with IN B-PP O
me PRP B-NP O
in IN B-PP O
3-4 CD B-NP O
months NNS I-NP O
. . O O
John NNP B-NP B-DOCTOR
V. NNP I-NP I-DOCTOR
Hood NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
Attending VBG B-NP O
note NN I-NP O
: : O O
Pt JJ B-NP O
seen VBN I-NP O
and CC I-NP O
discussed VBN B-VP O
with IN B-PP O
Dr. NNP B-NP O
Hood NNP I-NP B-DOCTOR
, , O O
and CC O O
agree VB B-VP O
with IN B-PP O
his PRP$ B-NP O
evaluation NN I-NP O
and CC I-NP O
plan NN I-NP O
. . O O
Pt NNP B-NP O
with IN B-PP O
symptoms NNS B-NP O
and CC I-NP O
signs NNS I-NP O
of IN B-PP O
impingement NN B-NP O
syndrome NN I-NP O
due JJ B-ADJP O
to TO B-PP O
rotator NN B-NP O
cuff NN I-NP O
tendinitis NN I-NP O
vs IN B-PP O
partial JJ B-NP O
tear VB I-NP O
, , O O
and CC O O
also RB B-ADVP O
tenderness NN B-NP O
and CC O O
positive JJ B-NP O
cross-over NN I-NP O
test NN I-NP O
c/w NN I-NP O
A-C NNP I-NP O
arthritis NN I-NP O
. . O O
Will MD B-VP O
check VB I-VP O
X-ray NN B-NP O
, , O O
get VB B-VP O
PA NNP B-NP O
for IN B-PP O
Vioxx NNP B-NP O
, , O O
and CC O O
would MD B-VP O
benefit VB I-VP O
from IN B-PP O
PT NNP B-NP O
referral NN I-NP O
. . O O
If IN B-SBAR O
no DT B-NP O
improvement NN I-NP O
, , O O
consider VBP B-VP O
MRI NNP B-NP O
vs IN B-PP O
empiric JJ B-NP O
subacromial/?A-C JJ I-NP O
joint JJ I-NP O
steroid NN I-NP O
injection NN I-NP O
. . O O
Seems NNS B-NP O
to TO B-VP O
have VB I-VP O
a DT B-NP O
painful JJ I-NP O
peripheral JJ I-NP O
neuropathy NN I-NP O
, , O O
cause VB B-VP O
uncertain JJ B-ADJP O
. . O O
Will NNP O O
try VBP B-VP O
low-dose JJ B-NP O
TCA NNP I-NP O
, , O O
would MD B-VP O
also RB I-VP O
check VB I-VP O
B12 NNP B-NP O
, , O O
consider VBP B-VP O
EMG/NCV. VBG I-VP O
Will MD O O
obtain VB B-VP O
cardiology NN B-NP O
review NN I-NP O
for IN B-PP O
CAD. NNP B-NP O
Regardless NNP I-NP O
of IN B-PP O
level NN B-NP O
of IN B-PP O
lipids NNS B-NP O
, , O O
there EX B-NP O
is VBZ B-VP O
evidence NN B-NP O
for IN B-PP O
benefit NN B-NP O
of IN B-PP O
statin NN B-NP O
, , O O
and CC O O
would MD B-VP O
encourage VB I-VP O
pt VB I-VP O
to TO I-VP O
resume VB I-VP O
. . O O
If IN B-PP O
current JJ B-NP O
chest NN I-NP O
pain NN I-NP O
syndrome NN I-NP O
more RBR B-NP O
likely JJ I-NP O
due JJ I-NP O
to TO B-PP O
GERD NNP B-NP O
than IN B-PP O
ischemia NN B-NP O
, , O O
could MD B-VP O
consider VB I-VP O
D/C NNP B-NP O
nitrates NNS I-NP O
. . O O
